2Scott IU ,Flynn HW,Rosenfeld P J, et al. Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema. Am J Ophthalmol,2003,136 : 737-739.
3Machemer R, Aaberg TM, Freeman HM, et al. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol, 1991,112: 159-165.
4Hui YN, Hu D. Prevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the disease. Graefes Arch Clin Exp Ophthalmol,1999,237: 601-605.
6Enaida H,Hata Y,Ueno A, et al. Possible benefits of triamcinolneassisted pars plana vitrectomy for retinal diseases. Retina, 2003,23:764-770.
7Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion.Arch Ophthalmol, 2002,120:1217-1219.
8Yamashita T, Doi N, Sakamoto T. Weak symptoms of bacterial endophthalmitis after a triamcinolone acetonide-assisted pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol, 2004, 242: 679-681.
二级参考文献5
1Hui Y N，Am J Ophthalmol，1989年，108卷，176页
2Jost B. Jonas,Ingrid Kreissig,Robert F. Degenring. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(9):782～783
3Taiji Sakamoto,Miho Miyazaki,Toshio Hisatomi,Takao Nakamura,Akifumi Ueno,Keiko Itaya,Tatsuro Ishibashi. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood–ocular barrier breakdown[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(6):423～429
4Yu-sheng Wang,Ulrike Friedrichs,Wolfram Eichler,Stephan Hoffmann,Peter Wiedemann. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(1):42～48
5Yan-Nian Hui,Hou-Cheng Liang,Yong-Shu Cai,Bernd Kirchhof,Klaus Heimann. Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretionopathy induced by macrophages[J] 1993,Graefe’s Archive for Clinical and Experimental Ophthalmology(2):109～114
10Hui YN, Hu D. Prevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the disease. Graefes Arch Clin Exp Ophthalmol 1999,237:601-605.
